Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) EBT Margin (2019 - 2025)

Pulmonx has reported EBT Margin over the past 7 years, most recently at 64.31% for Q3 2025.

  • Quarterly EBT Margin rose 412.0% to 64.31% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 61.39% through Sep 2025, up 972.0% year-over-year, with the annual reading at 66.71% for FY2024, 2106.0% up from the prior year.
  • EBT Margin was 64.31% for Q3 2025 at Pulmonx, down from 62.85% in the prior quarter.
  • Over five years, EBT Margin peaked at 55.28% in Q4 2024 and troughed at 146.14% in Q1 2022.
  • The 5-year median for EBT Margin is 84.0% (2023), against an average of 88.06%.
  • The largest YoY upside for EBT Margin was 21720bps in 2021 against a maximum downside of -5252bps in 2021.
  • A 5-year view of EBT Margin shows it stood at 93.77% in 2021, then increased by 3bps to 91.0% in 2022, then grew by 22bps to 70.75% in 2023, then grew by 22bps to 55.28% in 2024, then dropped by -16bps to 64.31% in 2025.
  • Per Business Quant, the three most recent readings for LUNG's EBT Margin are 64.31% (Q3 2025), 62.85% (Q2 2025), and 63.51% (Q1 2025).